PregLem is a Swiss based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine. The company was founded in June 2006 by Dr. Ernest Loumaye, a specialist in female reproductive medicine, and Mr. Eric Rolin, a finance executive in the pharmaceutical industry. PregLem currently has a 32 member strong team with expertise in Pre-Clinical and Clinical Product Development, CMC, Regulatory Affairs, Sales and Marketing and Corporate Finance, and is located in Geneva.
In October 2010, Gedeon Richter Plc announced the acquisition of PregLem, and the company became a member of the Richter Group.
T +41 (0)22 884 03 40 ▫ F +41 (0) 22 884 03 49 ▫ info@preglem.com
RICHTER ANNOUNCES THAT PREGLEM RECEIVES POSITIVE EMA/CHMP OPINION FOR ESMYA(R) FOR THE PRE-OPERATIVE TREATMENT OF UTERINE FIBROIDS (MYOMA)
> Read all the news